Barbalho SM, Goulart RA, Arano ALC, de Oliveira PGC ~ Aliment Pharmacol Ther
Lower treatment burden While retatrutide shows significant promise, Eli Lilly is likely to disrupt the market more imminently and more substantially following the launch of orforglipron in early 2026
The confusion between basal insulins and GLP-1 drugs extends across the entire insulin category, not just Toujeo
Ive gotten closer to God, Ive gotten closer to myself, Im a better father
People usually develop it from habits that they can change
While healthy fat tissue contains beneficial immune cells, excess weight transforms it into an inflammatory factory, releasing pro-inflammatory mediators like TNF-, IL-6, and free fatty acids